Pfizer says three drugs in Phase III trials for deadly cancers

06/5/2007 | Forbes

Pfizer says three of its cancer drugs are set to undergo large-scale Phase III trials for several deadly cancers, one of them for an extended indication. The firm said its Sutent for stomach and kidney cancers is being tested for liver cancer, its Axitinib for pancreatic cancer, and its CP-751,871 compound for non-small-cell lung cancer.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC